ArticlebioRxiv : the preprint server for biology2025
Frequency-Dependent Modulation of the Prefrontal Cortex by Low-Intensity Focused Ultrasound: Impact on Mesolimbic Dopamine Signaling.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Synchronized neural oscillations are fundamental for cognitive function and orchestrate inhibitory and excitatory neurotransmission and downstream signaling. We hypothesized that low-intensity focused ultrasound (LIFU) with frequency parameters mimicking oscillatory patterns would enable targeted neuromodulation. Building on prior findings of the ability of LIFU to modulate neurotransmission, we investigated the effects of frequency-modulated LIFU applied to the prelimbic cortex (PLC) on dopamine release in the nucleus accumbens (NAcc) core as well as neuronal and astrocytic activity. After three 80-second LIFU stimulations spaced 30 minutes apart, we found that LIFU excited or inhibited NAcc dopamine release for up to 90 minutes, and these effects were dependent on oscillation frequency and sex. In male rats, theta (8 Hz)-coupled beta (16 Hz) LIFU reduced both dopamine release by 58% and the level of the astrocytic marker GFAP by 50%. Similar decreases in dopamine density were observed in females. Delta (2 Hz)-coupled beta (16 Hz) stimulation produced similar inhibitory effects. Conversely, theta (5 Hz)-coupled gamma (50 Hz) LIFU increased dopamine release by 28% in males. However, similar excitation levels were observed only in females with an increased gamma frequency of 70 Hz (coupled with a theta frequency of 7 Hz). Histological analysis revealed no cell death, but both 8:16 Hz and 5:50 Hz LIFU elevated neuronal activation (cFOS) in the PLC in males, while 5:50 Hz also upregulated GFAP by 30%, suggesting astrocytic involvement. Thus, LIFU stimulation of the PLC can be frequency-tuned to selectively excite or inhibit dopaminergic signaling in the NAcc, suggesting a novel approach for manipulating neurotransmission.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.